Volpara IPO

New Zealand-based Volpara Health Technologies will meet fund managers this week ahead of a run at the ASX-boards.

Stockbroker Morgans is introducing fund managers to Volpara management in Sydney on Tuesday and Melbourne on Wednesday, seeking to drum up interest in the software company.
Volpara is understood to be lining up for a $20 million initial public offering, selling shares at 50¢ each. It is seeking to lodge a prospectus by March 21 and start trading on a normal basis on April 22.
Volpara has a suite of software applications that digitally analyse x-rays to assist in the early detection of breast cancer.
The company is seeking the equity injection to increase is sales force into the United States.
The IPO is expected to value Volpara at $71 million on a market capitalisation basis.
Volpara is overseen by venture capitalist Roger Allen, who co-founded venture capital fund manager Allen & Buckeridge. Allen lines up as chairman, while other directors include founding director and chief executive officer Ralph Highnam and Royal Women's Hospital chair Lyn Swinburne.


Read more: http://www.copyright link/street-talk#ixzz41X0ag1lH
Follow us: @FinancialReview on Twitter | financialreview on Facebook